Nasal Endoscopy | Rigid & Flexible Scope Examination — Cost, Top Hospitals & Success Rates | MyMedicPlus

Nasal endoscopy is a minimally invasive diagnostic procedure that allows direct visualisation of the nasal cavity, middle meatus, nasopharynx, and related sinonasal structures using a narrow-bore endoscope passed through one or both nostrils. It is the gold-standard examination for assessing the nasal airway and is performed as a routine outpatient procedure by ENT (ear, nose and throat) surgeons and rhinologists.

The procedure relies on two principal instrument types, each suited to different anatomical regions and clinical purposes:

Rigid nasal endoscopy uses the Hopkins rod-lens system — a precision optical system of aligned glass rods and lenses within a stainless steel tube of 2.7–4 mm outer diameter. The Hopkins rod delivers outstanding image clarity and brightness, far superior to flexible scopes. Three lens angles are used:

• 0° (straight/forward-viewing): Used for the initial systematic examination of the nasal cavity from the vestibule to the nasopharynx; visualises the inferior meatus, turbinates, nasal septum, and posterior choana.
• 30° (angled): Provides an offset superior view into the middle meatus — the critical corridor draining the maxillary, anterior ethmoid, and frontal sinuses. This is the most important angle for assessing the ostiomeatal complex in patients with sinusitis.
• 70° (wide-angle): Allows visualisation of the frontal sinus recess, sphenoid sinus ostium, and areas anterior to the middle turbinate; useful in post-operative surveillance after functional endoscopic sinus surgery (FESS).

Flexible nasal endoscopy uses a fibreoptic or chip-on-tip video nasopharyngoscope — a slim (typically 3.5–4 mm), steerable instrument that can follow the natural curvature of the nasal airway and nasopharynx, reaching the post-nasal space, Eustachian tube orifices, and glottis. It is better tolerated than rigid scopes by some patients and is the preferred instrument when a combined nasal and pharyngolaryngeal examination is required.

Both instruments are passed under topical anaesthesia — typically a spray or soaked pledgets of lignocaine (local anaesthetic) combined with xylometazoline (nasal decongestant to reduce mucosal congestion and improve visualisation). No sedation or general anaesthesia is required for diagnostic nasal endoscopy in cooperative adults.

Nasal endoscopy is indicated wherever disease of the nasal cavity, paranasal sinuses, or nasopharynx is suspected and where anterior rhinoscopy (simple visual examination of the nasal vestibule with a speculum) is insufficient to reach or visualise the relevant anatomy. Key indications include:

Chronic rhinosinusitis (CRS): The most common indication for nasal endoscopy. CRS is defined as persistent inflammation of the nose and sinuses for 12 or more weeks with symptoms of nasal obstruction, mucopurulent discharge, facial pain/pressure, and reduced sense of smell. Endoscopy characterises the disease as CRS with nasal polyps (CRSwNP) or without polyps (CRSsNP), assesses mucosal disease, identifies purulent secretion from sinus ostia, and guides management decisions.

Nasal polyps: Direct visualisation establishes the extent, origin, and response of nasal polyps to medical therapy (intranasal steroids, short oral steroid courses). Grading of polyp size and severity using endoscopic scoring systems guides surgical referral thresholds.

Epistaxis (nosebleed): Nasal endoscopy allows direct identification of the bleeding point — most commonly Little’s area (the anterior nasal septum in Kiesselbach’s plexus) but also the posterior nasal cavity (sphenopalatine artery territory) in recurrent or severe posterior epistaxis. Identification of the source enables targeted cauterisation under vision rather than blind anterior nasal packing.

CSF rhinorrhoea (cerebrospinal fluid leak): A clear, watery unilateral nasal discharge that increases on bending forward may represent CSF leakage through a defect in the skull base (cribriform plate, fovea ethmoidalis, or sphenoid roof). Nasal endoscopy localises the site of the leak — confirmed biochemically by beta-2 transferrin testing — to guide surgical planning for endoscopic skull base repair.

Nasal and nasopharyngeal tumours: Endoscopy is essential for direct visualisation, accurate localisation, and biopsy of suspicious mucosal lesions, including inverted papilloma, angiofibroma (in adolescent males), nasopharyngeal carcinoma, and sinonasal adenocarcinoma.

Post-operative surveillance: After FESS, endoscopy monitors healing, identifies synechiae (adhesions), detects early polyp recurrence, and guides clinic-based debridement of crusting and granulation tissue during the post-surgical healing phase.

Nasal endoscopy is suitable for the majority of adults and children (with age-appropriate technique and, in young children, possibly sedation or general anaesthesia for rigid endoscopy) who present with nasal or sinonasal symptoms warranting assessment beyond the capacity of anterior rhinoscopy.

Indications for referral and endoscopic examination:

• Persistent nasal obstruction not explained by obvious septal deviation on anterior examination
• Chronic rhinosinusitis symptoms for 12 or more weeks despite adequate medical therapy
• Recurrent acute sinusitis (three or more episodes per year)
• Nasal polyps suspected clinically or on imaging
• Unilateral nasal discharge, especially if blood-stained or clear and watery
• Recurrent or posterior epistaxis not controlled by anterior nasal intervention
• Suspected nasopharyngeal lesion (mass, asymmetry, adenoid hypertrophy in adults)
• Persistent unilateral anosmia or loss of smell
• Pre-operative assessment before functional endoscopic sinus surgery (FESS)

Pre-procedure preparation:

• No fasting is required for diagnostic nasal endoscopy under topical anaesthesia — the procedure is performed in an outpatient clinic and does not require sedation in cooperative adults.
• Anticoagulant medications (warfarin, direct oral anticoagulants, high-dose aspirin) are generally continued unless a biopsy is anticipated, in which case specialist advice should be sought.
• Patients should inform the clinician of any nasal surgery history, significant septal deviation, or allergy to local anaesthetic agents (lidocaine allergy is rare but should be documented).

Special populations: Children and anxious patients may benefit from prior application of topical anaesthetic drops, patient-centered explanation of the procedure, or distraction techniques. In young children under 5–6 years, rigid nasal endoscopy under sedation or general anaesthesia may be needed to achieve adequate examination quality. Flexible endoscopy is generally better tolerated in anxious individuals and children due to its smaller diameter and greater flexibility.

The nasal endoscopy procedure follows a standardised systematic examination protocol, though the specific instruments, angles, and focus areas are tailored to the clinical question being addressed.

Standard rigid nasal endoscopy procedure (three-pass technique):

• Preparation: The patient sits upright in an examination chair. Topical lignocaine 4–10% spray is applied to both nostrils for anaesthesia. Xylometazoline 0.1% nasal spray is applied to decongested the mucosa — this shrinks the inferior turbinate, opens the middle meatus, and dramatically improves visualisation.
• First pass (0° scope): The scope is passed along the floor of the nasal cavity lateral to the inferior turbinate, advancing to the nasopharynx. The inferior meatus, inferior turbinate, nasal septum, and posterior choana are examined.
• Second pass (30° scope): The scope is positioned under the middle turbinate to examine the middle meatus — the critical drainage corridor for the maxillary, anterior ethmoid, and frontal sinuses. This is where the ostiomeatal complex (OMC) is visualised, looking for mucosal oedema, polypoid change, or purulent secretion from sinus ostia.
• Third pass (30° or 70° scope): The scope is passed superior to the middle turbinate (into the olfactory cleft and superior meatus) and, if indicated, through the sphenoethmoid recess to the sphenoid sinus ostium.

Flexible nasal endoscopy: The scope is advanced under direct video vision along the nasal floor, around the inferior and middle turbinates into the post-nasal space. The Eustachian tube orifices, vault of the nasopharynx, and posterior choanae are visualised. The scope can then be advanced inferiorly to examine the oropharynx and larynx if laryngeal pathology is also suspected.

Biopsy during nasal endoscopy: When a mucosal lesion, mass, or suspicious tissue is identified, a biopsy can be performed during the endoscopic examination using cup biopsy forceps passed alongside the endoscope (for flexible scopes) or through a separate nasal passage (for rigid scope examination). Haemostasis is typically achieved with pressure or topical adrenaline. The biopsy specimen is sent for histopathology.

Lund-Mackay CT staging: While nasal endoscopy provides direct mucosal visualisation, CT scanning of the sinuses using the Lund-Mackay scoring system is performed as a complementary investigation before FESS. The Lund-Mackay score (0–24) grades opacification of each sinus group (maxillary, anterior ethmoid, posterior ethmoid, sphenoid, frontal, ostiomeatal complex) bilaterally on coronal CT slices. A score of 4 or more generally indicates disease severity justifying surgical consideration. CT defines the bony anatomy for surgical navigation planning, identifying variations such as Haller cells, Onodi cells, or dehiscent lamina papyracea that increase surgical risk.

Nasal endoscopy offers a combination of diagnostic yield, patient tolerability, and procedural versatility that makes it indispensable in contemporary ENT practice and superior to clinical examination alone for nasal and sinus disease.

Direct, real-time visualisation: Unlike CT or MRI, which provide structural imaging but not functional mucosal detail, nasal endoscopy allows the clinician to observe mucosal colour, texture, secretion character, and subtle anatomical variations directly under magnification. Subtle early polyps, small masses, and minimal mucosal disease visible on endoscopy may not be apparent on imaging.

High diagnostic yield and accuracy: Endoscopy substantially increases diagnostic sensitivity for chronic rhinosinusitis, nasal polyps, and nasopharyngeal pathology compared to anterior rhinoscopy and clinical history alone. It enables confident characterisation of disease extent and severity, directly informing treatment decisions (medical vs surgical management).

Biopsy capability in a clinic setting: The ability to obtain tissue under direct endoscopic vision — without general anaesthesia or theatre — allows rapid histological diagnosis of suspicious mucosal lesions, nasal masses, and nasopharyngeal abnormalities. This avoids the delay and resource requirements of surgical biopsy under general anaesthesia in many cases.

Guidance for surgical planning (FESS): Endoscopic findings combined with CT Lund-Mackay staging provide the anatomical road map required for functional endoscopic sinus surgery. The endoscopist identifies which sinuses are affected, which anatomical corridors are obstructed, and what specific surgical objectives are required, enabling a patient-specific rather than generic surgical approach.

Post-operative monitoring: The endoscope is the ideal surveillance tool after FESS, enabling clinic-based assessment of mucosal healing, early detection of synechiae requiring simple lysis, and monitoring for polyp recurrence — all without further anaesthesia or operating theatre time.

No radiation, no sedation (in adults): Diagnostic nasal endoscopy under topical anaesthesia carries no radiation dose and does not require sedation or general anaesthesia in cooperative adults, making it suitable for frequent monitoring and safe in all age groups.

Nasal endoscopy under topical anaesthesia is a very safe procedure with a low complication rate. Most adverse events are minor and self-limiting. Serious complications are rare in the diagnostic context.

Common, minor side effects:

• Transient discomfort and pressure sensation: The passage of the scope through the nasal cavity causes a pressure or fullness sensation, particularly around the middle turbinate. This is expected and well-tolerated by the majority of patients with adequate topical anaesthesia. The procedure takes only 5–15 minutes.
• Sneezing: Contact of the scope with the nasal mucosa or olfactory epithelium may trigger a sneeze reflex. Patients are advised to breathe steadily through the mouth during the examination.
• Minor epistaxis: A small amount of bleeding from the nasal mucosa during or after the procedure is common, particularly if the mucosa is inflamed, friable, or if a biopsy has been taken. It usually resolves within minutes with gentle nose pressure. Patients are advised not to blow their nose vigorously for 30 minutes after the procedure.

Less common complications:

• Vasovagal reaction: Some patients experience a vasovagal episode (feeling faint, nausea, sweating, bradycardia) during or after nasal endoscopy, triggered by the stimulation of vagal afferents in the nasal mucosa. Patients are asked to remain seated for several minutes after the procedure. Lying the patient flat typically resolves the episode promptly.
• Local anaesthetic reaction: True allergy to lidocaine is very rare. More commonly, patients may experience mild systemic absorption effects (light-headedness, metallic taste) if high volumes of lignocaine are used or the mucosa is particularly vascular. Doses are kept within safe limits.
• More significant epistaxis (post-biopsy): Biopsy in a highly vascular area — such as an angiofibroma, vascular polyp, or from the posterior nasal cavity — can result in more significant bleeding requiring topical adrenaline application, diathermy, or on rare occasions formal nasal packing. Patients on anticoagulants are at higher risk.

Infection: Transmission of infection via endoscopic examination is prevented by rigorous instrument decontamination following COSHH-compliant protocols (manual cleaning, automated endoscope reprocessor, or disposable single-use scopes where available). Endoscopy-associated infection is extremely rare when decontamination standards are maintained.

The follow-up plan after nasal endoscopy depends on the findings at examination and whether intervention (biopsy or treatment) was performed at the same visit.

For diagnostic-only examination:

• Patients can return to normal activities immediately after the procedure. Avoiding vigorous nose blowing for 30–60 minutes is advisable if the mucosa appeared friable or inflamed.
• The ENT clinician will discuss findings directly after the examination in most outpatient settings. If significant pathology is identified, further investigation (CT sinus, MRI, biopsy) will be arranged or explained.
• If findings are normal or consistent with mild rhinitis, the clinician may recommend or optimise medical management (intranasal corticosteroid spray, nasal saline irrigation, allergen avoidance) with a planned review appointment.

After biopsy:

• Histopathology results are typically available within 3–7 working days from a standard biopsy specimen; urgent processing for suspected malignancy may be arranged within 1–3 days.
• A follow-up clinic appointment is scheduled to discuss histology results and plan further management. If malignancy is confirmed, urgent referral to a head and neck multidisciplinary team (MDT) is initiated.
• Patients are advised to contact the clinic immediately if bleeding resumes, becomes heavy, or persists for more than 30 minutes after leaving the clinic.

Pre-surgical follow-up (FESS planning):

• If nasal endoscopy and CT Lund-Mackay staging have confirmed surgical disease (CRS with nasal polyps, obstructed ostia, or recurrent sinusitis), the patient is counselled about FESS. Pre-operative CT scan is formally reviewed by the surgeon to plan the operative approach, identify anatomical variations, and brief the surgical team.
• Medical optimisation — a pre-operative course of intranasal steroids or short oral prednisolone — is often prescribed to reduce mucosal inflammation and intraoperative bleeding.

Post-FESS surveillance:

• After FESS, rigid nasal endoscopy is performed at 1–2 week intervals in the early post-operative phase (typically 2–4 clinic visits) to aspirate mucus, remove crusting, lyse early synechiae, and assess mucosal healing. Subsequent surveillance is tailored to healing response and disease recurrence risk.

The cost of nasal endoscopy depends on the clinical setting, the type of endoscopy performed, whether a biopsy is taken, and the healthcare system in which treatment is sought.

Outpatient diagnostic endoscopy: In the United Kingdom, nasal endoscopy performed during an NHS outpatient ENT consultation is covered without direct patient charge. In private ENT practice in the UK, a diagnostic flexible or rigid nasal endoscopy performed at a consultation is typically included within the consultation fee (£150–£350) or charged separately at £80–£200. In the United States, the procedure is billed under specific CPT codes; the patient cost varies by insurance plan but typically ranges from USD 150–800 depending on in-network status, whether contrast or biopsy is added, and the practice setting (office vs hospital outpatient).

Biopsy: A nasal or nasopharyngeal biopsy taken during endoscopy incurs additional charges for histopathology laboratory processing (£50–£150 in the UK private sector; USD 100–400 in the US). Urgent or specialist histopathological analysis (immunohistochemistry, molecular testing) adds further cost.

CT sinus Lund-Mackay staging: CT scanning of the paranasal sinuses requested as a complement to nasal endoscopy for FESS planning costs approximately £250–£600 in the UK private sector, USD 500–2,000 in the US (before insurance), and USD 80–250 in India or Thailand.

Medical tourism for ENT care: Patients seeking diagnostic nasal endoscopy, CT sinus, and ENT consultation as part of a comprehensive rhinology assessment abroad can access equivalent-quality services at significantly lower cost in India (Apollo Hospitals, Fortis, Manipal), Thailand, Malaysia, Hungary, and Turkey. Full rhinology assessment including endoscopy, CT sinus, and specialist consultation may cost USD 200–600 in these destinations, compared to USD 1,500–4,000 in the US or UK private system. MyMedicPlus can assist in arranging these services at accredited ENT centres.

While nasal endoscopy provides direct visualisation and remains the gold standard for assessment of the nasal cavity and sinonasal structures, several alternatives and complementary investigations are used in clinical practice.

Anterior rhinoscopy: The simplest examination — using a nasal speculum and headlight or otoscope — visualises the nasal vestibule, anterior septum, anterior inferior turbinate, and very distal nasal cavity. Adequate for diagnosing obvious septal deviation, anterior polyps, or anterior epistaxis source. It cannot visualise the middle meatus, posterior nasal cavity, nasopharynx, or olfactory cleft — the regions most relevant to sinusitis, posterior epistaxis, and nasopharyngeal pathology.

CT sinus (Computed Tomography): Coronal CT of the paranasal sinuses using the Lund-Mackay protocol provides detailed assessment of sinus opacification, anatomical variations (Haller cells, agger nasi cells, deviated septum, paradoxical turbinate), and osseous landmarks. CT is the essential pre-operative planning tool for FESS and the best modality for assessing bony erosion in tumours. Limitation: CT does not assess mucosal texture, secretion character, or subtle mucosal inflammation; it also involves ionising radiation and does not enable biopsy.

MRI of sinuses: Superior to CT for soft tissue characterisation of nasal and paranasal sinus tumours (distinguishing secretion from soft tissue, assessing intracranial or orbital extension), CSF leak localisation, and fungal sinusitis characterisation. Not suitable for pre-operative bony anatomy mapping before FESS. No radiation. Complement to — not replacement for — endoscopy in tumour assessment.

Plain sinus X-rays (Waters’ view): Historically used to assess air-fluid levels in acute sinusitis. Now largely superseded by CT and clinical/endoscopic diagnosis; poor sensitivity and specificity for chronic sinusitis and polyps.

Allergy testing and microbiological nasal swabs: Complementary investigations — not alternatives to endoscopy — that provide aetiological information about the inflammatory/infective drivers of rhinosinusitis to guide targeted treatment.

In summary, nasal endoscopy is the frontline diagnostic tool for experienced ENT assessment, while CT and MRI serve as complementary cross-sectional imaging to extend diagnostic information — particularly regarding disease extent beyond the visible nasal cavity and surgical planning requirements.